Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 3369
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03088878 | A Study of Cirmtuzumab and Ibrutinib in Patients With B-Cell Lymphoid Malignancies | ||
| NCT01375985 | Safety Study of Single Administration Intravenous Treatment for Influenza | ||
| NCT05012943 | The ARCT-154 Self-Amplifying RNA Vaccine Efficacy Study (ARCT-154-01) | ||
| NCT06572449 | Study to Assess Safety and Effectiveness of Slowly Increasing Dose and Food Effect of KarXT in Participants With Schizophrenia | ||
| NCT07523048 | Dextromethorphan-Bupropion on Striatal Activity in Adults With Major Depressive Disorder | ||
| NCT00846547 | Open-Label Study of the Safety and Tolerability of STX209 in Subjects With Autism Spectrum Disorders | ||
| NCT05867914 | Early Feasibility Study Evaluating the 3P-100 Device in Subjects With PH-ILD | ||
| NCT04572906 | Safety and Efficacy of NTX-001 Compared to SOC in Acute Single Peripheral Nerve Injuries | ||
| NCT02300233 | The COMPASS Study: A Study of Volanesorsen (Formally ISIS-APOCIIIRx) in Patients With Hypertriglyceridemia | ||
| NCT02638038 | This is a Randomized Study Comparing Two Doses of INT131 ( 3 mg and 1 mg) Administered Orally (PO) Daily (QD) Versus Placebo 1 Tablet PO QD in Subjects With Treatment-naïve RRMS for ≤ 3 Years | ||
| NCT05851547 | Dose Escalation For INtraprostatic LEsions | ||
| NCT04793958 | Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10) | ||
| NCT04358406 | Rhu-pGSN for Severe Covid-19 Pneumonia | ||
| NCT04572776 | Phase 3 Study to Assess Resiniferatoxin vs Standard of Care for the Treatment of Intractable Cancer Pain | ||
| NCT02437487 | SER-109 Versus Placebo to Prevent Recurrent Clostridium Difficile Infection (RCDI) | ||
| NCT01458106 | Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Recombinant Coagulation Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously Treated Pediatric Subjects With Hemophilia A | ||
| NCT05475184 | A Study to Evaluate the Efficacy and Safety of JPI-547 in Platinum-resistant, Advanced/Relapsed Ovarian Cancer Subjects Previously Treated With a PARP Inhibitor | ||
| NCT07204938 | A Long-Term Study of Navenibart in Participants With Hereditary Angioedema | ||
| NCT06029426 | Study to Evaluate the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder | ||
| NCT07123415 | A Phase 1 Study of APX-343A as Monotherapy or in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors | ||
| NCT04064125 | Dermal Cumulative Irritant Patch Study | ||
| NCT02597478 | Fentanyl Sublingual Spray for Exercise-Induced Breakthrough Dyspnea | ||
| NCT06419608 | Efficacy and Safety Study of BHV-7000 Monotherapy in Major Depression | ||
| NCT03872206 | Study of HPN536 in Patients With Advanced Cancers Associated With Mesothelin Expression | ||
| NCT04562389 | Study of Selinexor in Combination With Ruxolitinib in Myelofibrosis | ||
| NCT04879017 | FHD-286 in Subjects With Metastatic Uveal Melanoma | ||
| NCT04847440 | A Study of Safety and Efficacy of ATI-2173 in Combination With Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis B Virus Infection and in Subjects With Hepatitis D Virus Coinfection | ||
| NCT01457417 | A Study of DKN-01 in Multiple Myeloma or Advanced Solid Tumors | ||
| NCT03058289 | A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6 | ||
| NCT04416126 | Safety, Tolerability and Pharmacokinetics of ARCT-810 in Healthy Adult Subjects | ||
| NCT07465835 | A Study of ELA026 in Participants With Relapsed/Refractory (R/R) T/NK Cell Malignancies (TCMs) | ||
| NCT01349868 | PT005 MDI Dose Ranging Versus Foradil Aerolizer Study | ||
| NCT00820703 | The ASCEND Study: A Study to Investigate the Safety and Clinical Effect of Nexagon to Treat Slow Healing Diabetic Foot Ulcers | ||
| NCT02127970 | Single Dose vs. Two Dose Regimen of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections | ||
| NCT01619683 | Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism | ||
| NCT05656027 | Phase 3 Evaluation of the Safety and Efficacy of LNZ100 & LNZ101 for the Treatment of Presbyopia | ||
| NCT03401788 | A Phase 2 Study of Belzutifan (PT2977, MK-6482) for the Treatment of Von Hippel Lindau (VHL) Disease-Associated Renal Cell Carcinoma (RCC) (MK-6482-004) | ||
| NCT04626505 | Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 Inhibition in Japan. | ||
| NCT04471727 | A Study in Participants With Advanced Cancers Associated With Expression of DLL3 (MK-6070-001/HPN328-4001) | ||
| NCT03455270 | G1T48, an Oral SERD, Alone and in Combination With Palbociclib in ER-Positive, HER2-Negative Advanced Breast Cancer | ||
| NCT03506854 | Study of ISIS 681257 in Patients With Renal Impairment Compared to Healthy Patients | ||
| NCT05060276 | Study to Assess an Anti-Trop2 Antibody Drug Conjugate in Relapsed or Refractory Solid Tumors | ||
| NCT05329103 | A Study to Evaluate PEEL-224 in Patients With Advanced Solid Tumors | ||
| NCT04892641 | Phase 1 Study of Epetraborole Tablets | ||
| NCT02724527 | Study of Cavosonstat (N91115) in CF Patients Who Are Heterozygous for F508del-CFTR and a Gating Mutation and Being Treated With Ivacaftor | ||
| NCT04914286 | A Study of GFH018 in Combination With Toripalimab in Patients With Advanced Solid Tumors | ||
| NCT02973269 | DaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis | ||
| NCT02198664 | Oral Desensitization to Peanut in Peanut Allergic Children and Adults Using CPNA Peanut OIT Safety Follow-On Study | ||
| NCT00908063 | Safety and Tolerability of Oxycyte in Patients With Traumatic Brain Injury (TBI) | ||
| NCT03397706 | Dose Escalation & Expansion Study of Oral VRx-3996 & Valganciclovir in Subjects With EBV+ Lymphoid Malignancies |
